David G. McLeod

George Washington University — United States

Medicine · Health Sciences

70h-index17.8kcitations481works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(304), Prostate Cancer Diagnosis and Treatment(186), Cancer, Lipids, and Metabolism(51), Urologic and reproductive health conditions(42), Hormonal and reproductive studies(25)

Publications481 total

Response of human iPSC-cardiomyocytes to adrenergic drugs assessed by high-throughput pericellular oxygen measurements and computational modeling
Journal of Molecular and Cellular Cardiology Plus·2026Open Access
Response of human iPSC-cardiomyocytes to adrenergic drugs assessed by high-throughput pericellular oxygen measurements and computational modeling
2025Open Access
Pericellular oxygen dynamics in human cardiac fibroblasts and iPSC-cardiomyocytes in high-throughput plates: insights from experiments and modeling
Journal of Molecular and Cellular Cardiology Plus·2025· 2 citedOpen Access
Pericellular oxygen dynamics in human cardiac fibroblasts and iPSC-cardiomyocytes in high-throughput plates: insights from experiments and modeling
2025Open Access
Filamin A Is a Prognostic Serum Biomarker for Differentiating Benign Prostatic Hyperplasia from Prostate Cancer in Caucasian and African American Men
Cancers·2024· 4 citedOpen Access
A standard 96-well based high throughput microfluidic perfusion biofilm reactor for in situ optical analysis
Biomedical Microdevices·2023· 1 citedOpen Access
High-throughput optical sensing of peri-cellular oxygen in cardiac cells: system characterization, calibration, and testing
Frontiers in Bioengineering and Biotechnology·2023· 6 citedOpen Access
High-throughput optical sensing of peri-cellular oxygen in cardiac cells: system characterization, calibration, and testing
2023Open Access
A handheld plug-and-play microfluidic liquid handling automation platform for immunoassays
HardwareX·2023· 4 citedOpen Access
Abstract 2196: Serum Filamin A is a prognostic biomarker for screening benign prostatic hyperplasia vs prostate cancer in Caucasian and African American men
Cancer Research·2023
Table S1, S2 from Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells
2023Open Access
Data from Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells
2023Open Access
Table S1, S2 from Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells
2023Open Access
Data from Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells
2023Open Access
Supplementary Tables S1-S4 from Higher Expression of the Androgen-Regulated Gene <i>PSA/HK3</i> mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
2023Open Access
Supplementary Data from Delineation of <i>TMPRSS2-ERG</i> Splice Variants in Prostate Cancer
2023Open Access
Data from Delineation of <i>TMPRSS2-ERG</i> Splice Variants in Prostate Cancer
2023Open Access
Supplementary Figures S6- S12 from Identification of a Small Molecule That Selectively Inhibits ERG-Positive Cancer Cell Growth
2023Open Access
Supplementary Data from Delineation of <i>TMPRSS2-ERG</i> Splice Variants in Prostate Cancer
2023Open Access
Data from Identification of a Small Molecule That Selectively Inhibits ERG-Positive Cancer Cell Growth
2023Open Access
page 1 of 25Next →

Frequent Co-authors

Judd W. Moul(24), Shiv Srivastava(15), Isabell A. Sesterhenn(13), Leon Sun(8), György Petrovics(8), Yongmei Chen(6), Christopher L. Amling(5), Leo Kusuda(5), Wade J. Sexton(5), Douglas W. Soderdahl(5), Timothy F. Donahue(5), Linda Xu(5), Peter Iversen(5), Bungo Furusato(4), Hongyu Wu(4), Andrew Chung(4), William A. See(4), Manfred P. Wirth(4), Peter R. Carroll(4), Mario A. Eisenberger(3)